Terms: = Lung cancer AND CUX1, ENSG00000160967, P39880, p75, p200, p110, p100, Nbla10317, CUX, COY1, CDP, CASP, 1523 AND Treatment
53 results:
1. [Long-term outcome of patients with rectal cancer who achieve complete or near complete clinical responses after neoadjuvant therapy: a multicenter registry study of data from the Chinese Watch and Wait Database].
Zhao YM; Wang WH; Zhang W; Wang L; Li S; Wang JW; Liao LE; Yu GY; Sun Z; Qu YL; Gong Y; Lu Y; Wu T; Li YF; Wang Q; Zhao GH; Xiao Y; Ding PR; Zhang Z; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):372-382. PubMed ID: 38644243
[No Abstract] [Full Text] [Related]
2. A systematic review on the qualitative experiences of people living with lung cancer in rural areas.
Ali N; Nelson D; McInnerney D; Quaife SL; Laparidou D; Selby P; Kane R; Civello S; Skinner D; Pogson Z; Peake MD; Harding-Bell A; Cooke S
Support Care Cancer; 2024 Feb; 32(3):144. PubMed ID: 38316704
[TBL] [Abstract] [Full Text] [Related]
3. Tetrahydrobiopterin from cyanide-degrading bacterium Bacillus pumilus strain SVD06 induces apoptosis in human lung adenocarcinoma cell (A549).
Mahendran R; Selvaraj SP; Dhanapal AR; Sarasa SB; Mathias BM; Thankappan B; Femil Selta DR; Naveen P; Poorani R; Sundhar N; Pillai MM; Selvakumar R; Huang CY; Eswaran R; Angayarkanni J
Biotechnol Appl Biochem; 2023 Dec; 70(6):2052-2068. PubMed ID: 37731306
[TBL] [Abstract] [Full Text] [Related]
4. treatment burden in individuals living with and beyond cancer: A systematic review of qualitative literature.
Adam R; Nair R; Duncan LF; Yeoh E; Chan J; Vilenskaya V; Gallacher KI
PLoS One; 2023; 18(5):e0286308. PubMed ID: 37228101
[TBL] [Abstract] [Full Text] [Related]
5. Cost-effectiveness analysis of lungLB for the clinical management of patients with indeterminate pulmonary nodules.
Schneider JE; Davies S; Do Valle M; Chami N; Pagano PC; Anderson D; Donovan MJ
J Med Econ; 2023; 26(1):342-347. PubMed ID: 36802981
[TBL] [Abstract] [Full Text] [Related]
6. Impact of enteral immunonutrition on infectious complications and immune and inflammatory markers in cancer patients undergoing chemotherapy: A systematic review of randomised controlled trials.
Miller LJ; Douglas C; McCullough FS; Stanworth SJ; Calder PC
Clin Nutr; 2022 Oct; 41(10):2135-2146. PubMed ID: 36067585
[TBL] [Abstract] [Full Text] [Related]
7. Azithromycin and Ceftriaxone Differentially Activate NLRP3 in LPS Primed cancer Cells.
Tezcan G; Alsaadi M; Hamza S; Garanina EE; Martynova EV; Ziganshina GR; Farukshina ER; Rizvanov AA; Khaiboullina SF
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012769
[TBL] [Abstract] [Full Text] [Related]
8. Galangin/β-Cyclodextrin Inclusion Complex as a Drug-Delivery System for Improved Solubility and Biocompatibility in Breast cancer treatment.
Abbas ZS; Sulaiman GM; Jabir MS; Mohammed SAA; Khan RA; Mohammed HA; Al-Subaiyel A
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889394
[TBL] [Abstract] [Full Text] [Related]
9.
Li H; Li X; Lan S; Zuo X; Du T; Liu Y; Zhang C; Zhu J; Cheng Y
Tumori; 2023 Jun; 109(3):276-281. PubMed ID: 35723064
[TBL] [Abstract] [Full Text] [Related]
10. Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab.
Menzies-Gow A; Hoyte FL; Price DB; Cohen D; Barker P; Kreindler J; Jison M; Brooks CL; Papeleu P; Katial R
Adv Ther; 2022 May; 39(5):2065-2084. PubMed ID: 35287231
[TBL] [Abstract] [Full Text] [Related]
11. Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario.
Cantini L; Mentrasti G; Russo GL; Signorelli D; Pasello G; Rijavec E; Russano M; Antonuzzo L; Rocco D; Giusti R; Adamo V; Genova C; Tuzi A; Morabito A; Gori S; Verde N; Chiari R; Cortellini A; Cognigni V; Pecci F; Indini A; De Toma A; Zattarin E; Oresti S; Pizzutilo EG; Frega S; Erbetta E; Galletti A; Citarella F; Fancelli S; Caliman E; Della Gravara L; Malapelle U; Filetti M; Piras M; Toscano G; Zullo L; De Tursi M; Di Marino P; D'Emilio V; Cona MS; Guida A; Caglio A; Salerno F; Spinelli G; Bennati C; Morgillo F; Russo A; Dellepiane C; Vallini I; Sforza V; Inno A; Rastelli F; Tassi V; Nicolardi L; Pensieri V; Emili R; Roca E; Migliore A; Galassi T; Rocchi MLB; Berardi R
ESMO Open; 2022 Apr; 7(2):100406. PubMed ID: 35219245
[TBL] [Abstract] [Full Text] [Related]
12. Evaluation of the Anticancer Potential of Crude, Irradiated
Abdelglil MI; Abdallah SO; El-Desouky MA; Alfaifi MY; Elbehairi SEI; Mohamed AF
Molecules; 2021 Nov; 26(22):. PubMed ID: 34834153
[TBL] [Abstract] [Full Text] [Related]
13. Value of low-dose spiral CT combined with circulating miR-200b and miR-200c examinations for lung cancer screening in physical examination population.
Wang YZ; Lv YB; Li GY; Zhang DQ; Gao Z; Gai QZ
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(19):6123-6130. PubMed ID: 34661272
[TBL] [Abstract] [Full Text] [Related]
14. Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.
Dennett EJ; Janjua S; Stovold E; Harrison SL; McDonnell MJ; Holland AE
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013384. PubMed ID: 34309831
[TBL] [Abstract] [Full Text] [Related]
15. Prophylactic Cranial Irradiation in Patients With High-Risk Metastatic Non-Small Cell lung cancer: Quality of Life and Neurocognitive Analysis of a Randomized Phase II Study.
Maldonado F; Gonzalez-Ling A; Oñate-Ocaña LF; Cabrera-Miranda LA; Zatarain-Barrón ZL; Turcott JG; Flores-Estrada D; Lozano-Ruiz F; Cacho-Díaz B; Arrieta O
Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):81-92. PubMed ID: 33915217
[TBL] [Abstract] [Full Text] [Related]
16. Alterations in the Global Proteome and Phosphoproteome in Third Generation EGFR TKI Resistance Reveal Drug Targets to Circumvent Resistance.
Zhang X; Maity TK; Ross KE; Qi Y; Cultraro CM; Bahta M; Pitts S; Keswani M; Gao S; Nguyen KDP; Cowart J; Kirkali F; Wu C; Guha U
Cancer Res; 2021 Jun; 81(11):3051-3066. PubMed ID: 33727228
[TBL] [Abstract] [Full Text] [Related]
17. OTUD7B suppresses Smac mimetic-induced lung cancer cell invasion and migration via deubiquitinating TRAF3.
Zhang B; Yang C; Wang R; Wu J; Zhang Y; Liu D; Sun X; Li X; Ren H; Qin S
J Exp Clin Cancer Res; 2020 Nov; 39(1):244. PubMed ID: 33198776
[TBL] [Abstract] [Full Text] [Related]
18. CD271 is a negative prognostic factor and essential for cell proliferation in lung squamous cell carcinoma.
Mochizuki M; Nakamura M; Sibuya R; Okazaki T; Abe J; Nakagawa T; Takahashi S; Yamazaki T; Imai T; Takano A; Ito H; Yokose T; Miyagi Y; Daigo Y; Sato I; Satoh K; Sugamura K; Yamaguchi K; Tamai K
Lab Invest; 2019 Sep; 99(9):1349-1362. PubMed ID: 31019292
[TBL] [Abstract] [Full Text] [Related]
19. The outcomes of an impaired powerhouse in KRAS mutant lung adenocarcinoma cells by Elesclomol.
Albayrak G; Korkmaz FD; Tozcu D; Dogan Turacli I
J Cell Biochem; 2019 Jun; 120(6):10564-10571. PubMed ID: 30628735
[TBL] [Abstract] [Full Text] [Related]
20. cux1-ALK, a Novel ALK Rearrangement That Responds to Crizotinib in Non-Small Cell lung cancer.
Zhang M; Wang Q; Ding Y; Wang G; Chu Y; He X; Wu X; Shao YW; Lu K
J Thorac Oncol; 2018 Nov; 13(11):1792-1797. PubMed ID: 30010043
[TBL] [Abstract] [Full Text] [Related]
[Next]
